Cipla Ltd

  • BSE Code : 500087
  • NSE Symbol : CIPLA
  • ISIN : INE059A01026
  • Industry :PHARMACEUTICALS - INDIAN - BULK DRUGS & FORMLN

up-arrow 1,396.30 -5.70(-0.41%)

Open Price (₹)

1,405.00

Prev. Close (₹)

1,402.00

Volume (No’s)

339,958

Market Cap (₹)

113,263.46

Low Price (₹)

1,390.20

High Price (₹)

1,408.00

 

Board Meetings

Start Date End Date Purpose
28-Sep-2026 27-Oct-2026 Cipla Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2026 inter alia to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended 30th September 2026. In terms of the Companys Code of Conduct for prevention of Insider Trading the Trading window for dealing in the securities of the Company will be closed from Thursday 1st October 2026 till Thursday 29th October 2026 (both days inclusive) for the purpose of financial results. Please find enclosed the financial results for the quarter and half year ended 30th September, 2026. Please find enclosed the intimation for appointment of Ms Rashmi Joshi as an additional and independent director of the company w.e.f. 27th October, 2026 for a period of 5 years. (As per BSE Announcement dated on: 27.10.2026)
24-Jun-2026 23-Jul-2026 Cipla Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/07/2026 inter alia to consider and approve the unaudited standalone and consolidated financial results for the quarter ended 30th June 2026. In terms of the Companys Code of Conduct for prevention of Insider Trading the Trading window for dealing in the securities of the Company will be closed from Wednesday 1st July 2026 till Saturday 25th July 2026 (both days inclusive) for the purpose of financial results. Please find attached financial results for quarter ended 30th June, 2026 Please find enclosed disclosure on Regulation 30(5). (As per BSE Announcement dated on: 23.07.2026)
31-Mar-2026 13-May-2026 Cipla Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2026 inter alia to consider and approve 1. the Standalone and Consolidated Audited Financial Results of the Company for the quarter and year ended 31st march 2026. 2. Recommend final dividend for the year ended 31st march 2026 if any. In terms of the Companys Code of Conduct for prevention of Insider Trading the Trading window for dealing in the securities of the Company is closed from Wednesday 1st April 2026 till Friday 15th May 2026 (both days inclusive) for the purpose of financial results. Declaration of final dividend of INR 13 per equity share for FY ended March 31, 2026 Record date for the purpose of payment of final dividend for FY 2025-26 Outcome of the Board meeting held on 13th May, 2026 (As Per BSE Announcement Dated on 12.05.2026)
19-Mar-2026 19-Mar-2026 Please find attached intimation regarding appointment of Vice Chairman and tenure completion of ID Investment in Cipla (EU) Limited, wholly owned subsidiary of the Company
23-Dec-2025 23-Jan-2026 Quarterly Results Please find attached financial results for quarter and nine months ended 31st December 2025 The Board meeting of the Company which commenced today at 11:00 a.m. (IST) and is still in progress. Cipla Limited has informed the Exchange that the Board has approved the re-appointment of Mr P R Ramesh as Independent Director of the Company for a second term of five consecutive years, subject to approval of the shareholders. (As per BSE Announcement dated on: 23.01.2026)
BSE Delayed data sourced at 5 mins : www.bseindia.com | NSE Delayed data sourced at 15 mins : www.nseindia.com

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew